Gene Therapy Research Reveals Intraspecies Warfare Limits Strain Coexistence in Human Skin Microbiomes

Strategic Insights -

A study published in Nature Microbiology has shed light on the critical factors that determine the success of gene therapy in targeting the human skin microbiome. The research, led by Tami D. Lieberman and colleagues from the Massachusetts Institute of Technology, demonstrated that intraspecies warfare between bacteria restricts the coexistence of strains in the human skin microbiome. The study, supported by the U.S. Department of Health & Human Services and the National Institute of General Medical Sciences, utilized genomic analysis and high-throughput agar competition assays to investigate the mechanisms underlying strain coexistence.

Key Takeaways:

  • The research identified that intraspecies warfare presents a significant barrier to strain coexistence in the human skin microbiome, with 14,884 pairwise interactions between Staphylococcus epidermidis isolates from 18 people.
  • The study found that antimicrobial production and resistance varied widely among strains, suggesting trade-offs between these factors and other fitness determinants.
  • The results emphasized that accounting for intraspecies warfare may be essential for designing long-lasting probiotic therapeutics.
  • The research team highlighted the importance of understanding the mechanisms underlying strain coexistence in the human microbiome, with implications for the development of gene therapy and microbiome engineering.

Statistics:

  • 14,884 pairwise interactions between Staphylococcus epidermidis isolates from 18 people were analyzed.
  • 18 people from 6 families were involved in the study.
  • 14,884 pairwise interactions resulted in 970 antagonistic interactions.
  • 18.2% of pairwise interactions led to antimicrobial production.

Sources:

  • Intraspecies Warfare Restricts Strain Coexistence In Human Skin Microbiomes. Nature Microbiology, 2025;10(7).
  • U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS).
  • Massachusetts Institute of Technology, Institute for Medical Engineering & Science, Cambridge, MA 02139, United States.
  • Nature Portfolio, Heidelberger Platz 3, Berlin, 14197, Germany.
  • Health & Medicine Week. August 1, 2025; p 70.